Find participating medical centers and current study status in each of them

    Find participating medical centers

    Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab

    • Autoimmune Disorder
    • Multiple Sclerosis (MS)
    • Neurodegenerative Disorder
    • Relapsing Multiple Sclerosis (RMS)